Latest OPTN reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Stock OptiNose
OptiNose logo

OptiNose OPTN

$ 1.12 7.69%
mail-toReport an Error

Country

 usaUSA

IPO year

 2017

Industry

 Drug manufacturers

Stock Exchange

 NASDAQ GLOBAL

CEO

 Mr. Peter Miller

Employees in the company

 221

Shares

 112 M

Market Cap[1]

 $ 126 M

EBITDA (LTM)

 $ -27.9 M

P/E (LTM)

 -

P/S (LTM)

 -

EPS (LTM)

 -

Other stocks of industry "Drug manufacturers"

Issuer Price % 24h Market Cap Exchange Country
AcelRx Pharmaceuticals AcelRx Pharmaceuticals
ACRX
 		$ 0.86 7.5 % $ 6.35 M Nasdaq Global Market usaUSA
Amryt Pharma plc Amryt Pharma plc
AMYT
 		$ 14.7 - $ 621 M Nasdaq Global Select Market britainBritain
Aerie Pharmaceuticals Aerie Pharmaceuticals
AERI
 		$ 15.25 - $ 754 M Nasdaq Global Market,SPB usaUSA
PetIQ PetIQ
PETQ
 		$ 13.6 1.64 % $ 400 M Nasdaq Global Select Market,SPB usaUSA
Agile Therapeutics Agile Therapeutics
AGRX
 		$ 0.6 10.11 % $ 58.2 M Nasdaq Capital Market usaUSA
Collegium Pharmaceutical Collegium Pharmaceutical
COLL
 		$ 37.86 -0.53 % $ 1.22 B Nasdaq Global Select Market usaUSA
Teligent, Inc. Teligent, Inc.
TLGT
 		$ 0.173 -13.85 % $ 16.1 M Nasdaq Global Select Market usaUSA
Recro Pharma Recro Pharma
REPH
 		$ 1.4 -4.76 % $ 65.3 M Nasdaq Global Select Market usaUSA
Athenex Athenex
ATNX
 		$ 0.2 -23.39 % $ 1.76 M Nasdaq Global Select Market usaUSA
PLx Pharma PLx Pharma
PLXP
 		$ 0.09 -27.8 % $ 2.56 M Nasdaq Capital Market usaUSA
Shineco, Inc. Shineco, Inc.
TYHT
 		$ 11.09 -3.90 % $ 97.2 M Nasdaq Global Select Market chinaChina
Johnson & Johnson Johnson & Johnson
JNJ
 		$ 149.85 0.6 % $ 380 B NYSE,SPB usaUSA
FSD Pharma FSD Pharma
HUGE
 		$ 0.35 0.83 % $ 69.7 M Nasdaq Capital Market canadaCanada
Lannett Company Lannett Company
LCI
 		$ 0.66 1.15 % $ 7.11 M NYSE usaUSA
ProPhase Labs ProPhase Labs
PRPH
 		$ 4.92 -8.72 % $ 78 M Nasdaq Capital Market usaUSA
Radius Health Radius Health
RDUS
 		$ 18.21 3.35 % $ 860 M Nasdaq Global Market usaUSA
GW Pharmaceuticals plc GW Pharmaceuticals plc
GWPH
 		$ 218.96 - $ 6.81 B Nasdaq Global Select Market britainBritain
Adamas Pharmaceuticals, Inc. Adamas Pharmaceuticals, Inc.
ADMS
 		$ 8.22 - $ 376 M Nasdaq Global Market usaUSA
Flexion Therapeutics, Inc. Flexion Therapeutics, Inc.
FLXN
 		$ 9.12 - $ 459 M Nasdaq Global Market usaUSA
Veru Veru
VERU
 		$ 1.37 -4.2 % $ 116 M Nasdaq Capital Market usaUSA

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.